0001020710--12-31 2023 Q1 false 0001020710 2023-01-01 2023-03-31 0001020710 2023-05-05 xbrli:shares iso4217:USD 0001020710 2022-01-01 2022-03-31 iso4217:USD xbrli:shares 0001020710 2023-03-31 0001020710 2022-12-31 0001020710 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001020710 us-gaap:SeriesBPreferredStockMember 2023-03-31 0001020710 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001020710 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001020710 2021-12-31 0001020710 2022-03-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001020710 us-gaap:CommonStockMember 2021-12-31 0001020710 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001020710 us-gaap:RetainedEarningsMember 2021-12-31 0001020710 us-gaap:TreasuryStockMember 2021-12-31 0001020710 us-gaap:NoncontrollingInterestMember 2021-12-31 0001020710 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001020710 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001020710 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001020710 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001020710 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001020710 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001020710 us-gaap:CommonStockMember 2022-03-31 0001020710 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001020710 us-gaap:RetainedEarningsMember 2022-03-31 0001020710 us-gaap:TreasuryStockMember 2022-03-31 0001020710 us-gaap:NoncontrollingInterestMember 2022-03-31 0001020710 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001020710 us-gaap:CommonStockMember 2022-12-31 0001020710 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001020710 us-gaap:RetainedEarningsMember 2022-12-31 0001020710 us-gaap:TreasuryStockMember 2022-12-31 0001020710 us-gaap:NoncontrollingInterestMember 2022-12-31 0001020710 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001020710 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001020710 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001020710 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001020710 us-gaap:TreasuryStockMember 2023-01-01 2023-03-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001020710 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001020710 us-gaap:CommonStockMember 2023-03-31 0001020710 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001020710 us-gaap:RetainedEarningsMember 2023-03-31 0001020710 us-gaap:TreasuryStockMember 2023-03-31 0001020710 us-gaap:NoncontrollingInterestMember 2023-03-31 0001020710 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 dxpe:segment 0001020710 dxpe:ProcessMachineryIncPMIMember dxpe:OtherCurrentandNoncurrentLiabilitiesMember 2023-03-31 0001020710 dxpe:BurlingameEngineersIncBurlingameMember dxpe:OtherCurrentandNoncurrentLiabilitiesMember 2023-03-31 0001020710 dxpe:DrydonEquipmentIncDrydonMember dxpe:OtherCurrentandNoncurrentLiabilitiesMember 2023-03-31 0001020710 dxpe:OtherCurrentandNoncurrentLiabilitiesMember dxpe:CiscoAirSystemsIncCiscoMember 2023-03-31 0001020710 dxpe:OtherCurrentandNoncurrentLiabilitiesMember dxpe:SullivanEnvironmentalTechnologiesIncSullivanMember 2023-03-31 0001020710 us-gaap:FairValueMeasurementsRecurringMember dxpe:ContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001020710 us-gaap:FairValueMeasurementsRecurringMember dxpe:ContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001020710 us-gaap:FairValueMeasurementsRecurringMember dxpe:ContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001020710 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember dxpe:ContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001020710 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember dxpe:ContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001020710 us-gaap:FairValueMeasurementsRecurringMember dxpe:ContingentConsiderationLiabilityMember us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001020710 us-gaap:FairValueMeasurementsRecurringMember dxpe:ContingentConsiderationLiabilityMember us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001020710 dxpe:PMIBurlingameDrydonCiscoAndSullivanMember us-gaap:FairValueInputsLevel3Member dxpe:ValuationTechniqueDiscountedCashFlowAndWeightedProbabilityOfPossiblePaymentsMember dxpe:AnnualizedEBITDAAndProbabilityOfAchievementMember 2023-03-31 xbrli:pure 0001020710 us-gaap:CarryingReportedAmountFairValueDisclosureMember dxpe:ABLRevolverMember 2023-03-31 0001020710 dxpe:ABLRevolverMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-03-31 0001020710 us-gaap:CarryingReportedAmountFairValueDisclosureMember dxpe:ABLRevolverMember 2022-12-31 0001020710 dxpe:ABLRevolverMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001020710 us-gaap:CarryingReportedAmountFairValueDisclosureMember dxpe:TermLoanBMember 2023-03-31 0001020710 dxpe:TermLoanBMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-03-31 0001020710 us-gaap:CarryingReportedAmountFairValueDisclosureMember dxpe:TermLoanBMember 2022-12-31 0001020710 dxpe:TermLoanBMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001020710 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-03-31 0001020710 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-03-31 0001020710 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001020710 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001020710 dxpe:ABLRevolverMember us-gaap:RevolvingCreditFacilityMember 2022-07-19 0001020710 dxpe:ABLRevolverMember us-gaap:RevolvingCreditFacilityMember 2022-07-19 2022-07-19 0001020710 dxpe:ABLRevolverMember us-gaap:RevolvingCreditFacilityMember 2023-03-31 0001020710 dxpe:SeniorSecuredTermLoanBMember us-gaap:SecuredDebtMember 2022-11-22 0001020710 dxpe:SeniorSecuredTermLoanBMember us-gaap:SecuredDebtMember 2022-11-22 2022-11-22 0001020710 dxpe:SeniorSecuredTermLoanBMember us-gaap:SecuredDebtMember 2023-03-31 0001020710 dxpe:ServiceCentersMember 2023-01-01 2023-03-31 0001020710 dxpe:InnovativePumpingSolutionsMember 2023-01-01 2023-03-31 0001020710 dxpe:SupplyChainServicesMember 2023-01-01 2023-03-31 0001020710 dxpe:ServiceCentersMember 2022-01-01 2022-03-31 0001020710 dxpe:InnovativePumpingSolutionsMember 2022-01-01 2022-03-31 0001020710 dxpe:SupplyChainServicesMember 2022-01-01 2022-03-31 0001020710 us-gaap:CommonStockMember dxpe:ShareRepurchaseProgramDecember2022Member 2022-12-15 0001020710 dxpe:ShareRepurchaseProgramDecember2022Member 2022-12-15 2022-12-15 0001020710 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001020710 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001020710 dxpe:FloridaValveEquipmentLLCAndEnvironmentalMDIncFloridaValveEMDMember us-gaap:SubsequentEventMember 2023-05-01 2023-05-01 0001020710 dxpe:RiordanMaterialsCorporationRiordanMember us-gaap:SubsequentEventMember 2023-05-01 2023-05-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)

[ | ☒ | ] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2023

or

[ | ☐ | ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to

Commission file number 0-21513
DXP Enterprises, Inc.
(Exact name of registrant as specified in its charter)

Texas |  | 76-0509661
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)

5301 Hollister, Houston, Texas 77040

(Address of principal executive offices, including zip code)

(713) 996-4700

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of Each Class | Trading Symbol | Name of Exchange on which Registered
Common Stock par value $0.01 | DXPE | NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] Accelerated filer [X] Non-accelerated filer [ ] Smaller reporting company [☐] Emerging growth company [☐]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [☐] No [X]
Number of shares of registrant's Common Stock, par value $0.01 per share outstanding as of May 5, 2023: 17,393,456.

DXP ENTERPRISES, INC. AND SUBSIDIARIES
TABLE OF CONTENTS
DESCRIPTION

Item |  | Page
PART I: FINANCIAL INFORMATION |
| ITEM 1. Financial Statements | 3
| a) Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income | 3
| b) Unaudited Condensed Consolidated Balance Sheets | 4
| c) Unaudited Condensed Consolidated Statements of Cash Flows | 5
| d) Unaudited Condensed Consolidated Statements of Equity | 6
| e) Notes to Unaudited Condensed Consolidated Financial Statements | 7
| ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 14
| ITEM 3. Quantitative and Qualitative Disclosures about Market Risk | 19
| ITEM 4. Controls and Procedures | 20
PART II: OTHER INFORMATION | 22
| ITEM 1. Legal Proceedings | 22
| ITEM 1A. Risk Factors | 22
| ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds | 22
| ITEM 3. Default upon Senior Securities | 23
| ITEM 4. Mine Safety Disclosures | 23
| ITEM 5. Other Information | 23
| ITEM 6. Exhibits | 24
| Signatures | 25

2

PART I: FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS
DXP ENTERPRISES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(in thousands, except per share amounts) (unaudited)

| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Sales | $ | 424,267 |  |  | $ | 319,411 |  |  |  |  |
Cost of sales | 299,226 |  |  | 224,527 |  |  |  |  |
Gross profit | 125,041 |  |  | 94,884 |  |  |  |  |
Selling, general and administrative expenses | 89,642 |  |  | 73,325 |  |  |  |  |
Income from operations | 35,399 |  |  | 21,559 |  |  |  |  |
Other (income) expense | (469) |  |  | 536 |  |  |  |  |
Interest expense | 11,521 |  |  | 5,162 |  |  |  |  |
Income before income taxes | 24,347 |  |  | 15,861 |  |  |  |  |
Provision for income tax expense | 6,767 |  |  | 3,332 |  |  |  |  |
Net income | 17,580 |  |  | 12,529 |  |  |  |  |
Net loss attributable to noncontrolling interest | — |  |  | (113) |  |  |  |  |
Net income attributable to DXP Enterprises, Inc. | 17,580 |  |  | 12,642 |  |  |  |  |
Preferred stock dividend | 23 |  |  | 23 |  |  |  |  |
Net income attributable to common shareholders | $ | 17,557 |  |  | $ | 12,619 |  |  |  |  |
Net income | $ | 17,580 |  |  | $ | 12,529 |  |  |  |  |
Currency translation adjustments | 98 |  |  | 1,669 |  |  |  |  |
Comprehensive income | $ | 17,678 |  |  | $ | 14,198 |  |  |  |  |
Earnings per share (Note 9) : |  |  |  |  |  |  |
Basic | $ | 1.00 |  |  | $ | 0.68 |  |  |  |  |
Diluted | $ | 0.95 |  |  | $ | 0.65 |  |  |  |  |
Weighted average common shares outstanding : |  |  |  |  |  |  |
Basic | 17,596 |  |  | 18,534 |  |  |  |  |
Diluted | 18,436 |  |  | 19,374 |  |  |  |  |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3

DXP ENTERPRISES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data) (unaudited)

| March 31, 2023 |  | December 31, 2022
ASSETS |  |  |
Current assets: |  |  |
Cash | $ | 58,282 |  |  | $ | 46,026 |
Restricted cash | 91 |  |  | 91 |
Accounts Receivable, net of allowance of $8,090 and $7,610 | 311,387 |  |  | 320,880 |
Inventories | 109,403 |  |  | 101,392 |
Costs and estimated profits in excess of billings | 41,967 |  |  | 23,588 |
Prepaid expenses and other current assets | 17,238 |  |  | 21,644 |
Income taxes receivable | 972 |  |  | 2,493 |
Total current assets | 539,340 |  |  | 516,114 |
Property and equipment, net | 47,754 |  |  | 45,964 |
Goodwill | 333,816 |  |  | 333,759 |
Other intangible assets, net | 74,830 |  |  | 79,585 |
Operating lease ROU assets | 52,353 |  |  | 57,402 |
Other long-term assets | 5,068 |  |  | 4,456 |
Total assets | $ | 1,053,161 |  |  | $ | 1,037,280 |
LIABILITIES AND EQUITY |  |  |
Current liabilities: |  |  |
Current maturities of debt | $ | 4,369 |  |  | $ | 4,369 |
Trade accounts payable | 106,320 |  |  | 100,784 |
Accrued wages and benefits | 26,617 |  |  | 26,260 |
Customer advances | 14,507 |  |  | 20,128 |
Billings in excess of costs and estimated profits | 10,183 |  |  | 10,411 |
Federal income taxes payable | 6,266 |  |  | — |
Short-term operating lease liabilities | 17,698 |  |  | 18,083 |
Other current liabilities | 38,795 |  |  | 32,866 |
Total current liabilities | 224,755 |  |  | 212,901 |
Long-term debt, net of unamortized debt issuance costs | 408,755 |  |  | 409,205 |
Long-term operating lease liabilities | 38,507 |  |  | 40,189 |
Other long-term liabilities | 4,770 |  |  | 4,701 |
Deferred income taxes liability | 2,090 |  |  | 4,892 |
Total long-term liabilities | 454,122 |  |  | 458,987 |
Total liabilities | 678,877 |  |  | 671,888 |
Commitments and contingencies (Note 10) |  |  |
Shareholders' equity: |  |  |
Series A and B preferred stock, $1.00 par value each; 1,000,000 shares authorized each | 16 |  |  | 16 |
Common stock, $0.01 par value, 100,000,000 shares authorized; 17,548,600 and 17,690,069 outstanding | 345 |  |  | 345 |
Additional paid-in capital | 214,309 |  |  | 213,937 |
Retained earnings | 268,106 |  |  | 250,549 |
Accumulated other comprehensive loss | (31,577) |  |  | (31,675) |
Treasury stock, at cost 2,774,887 and 2,435,352 shares | (76,915) |  |  | (67,780) |
Total DXP Enterprises, Inc. equity | 374,284 |  |  | 365,392 |
Total liabilities and equity | $ | 1,053,161 |  |  | $ | 1,037,280 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4

DXP ENTERPRISES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands) (unaudited)

| Three Months Ended March 31,
| 2023 |  | 2022
CASH FLOWS FROM OPERATING ACTIVITIES: |  |  |
Net income | 17,580 |  |  | 12,529 |
Reconciliation of net income to net cash provided by operating activities: |  |  |
Depreciation | 2,024 |  |  | 2,517 |
Amortization of intangible assets and deferred financing costs | 5,400 |  |  | 4,693 |
Provision for credit losses | 498 |  |  | (147) |
Fair value adjustment on contingent consideration | 342 |  |  | 531 |
Restricted stock compensation expense | 476 |  |  | 370 |
Deferred income taxes | (2,799) |  |  | 411 |
Changes in operating assets and liabilities, and other: |  |  |
Changes in Accounts receivables, net | 9,070 |  |  | (9,485) |
Accounts payable and accrued expenses | 13,311 |  |  | 9,603 |
Prepaid expenses and other assets | 8,844 |  |  | (3,603) |
Inventories | (8,006) |  |  | (10,910) |
Other | (20,291) |  |  | (3,829) |
Net cash provided by operating activities | $ | 26,449 |  |  | $ | 2,680 |
CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |
Purchase of property and equipment | (3,804) |  |  | (740) |
Acquisition of business, net of cash acquired | — |  |  | (5,316) |
Net cash used in investing activities | $ | (3,804) |  |  | $ | (6,056) |
CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |
Principal debt payments | (1,092) |  |  | (825) |
Preferred stock dividends paid | (23) |  |  | (23) |
Purchase of treasury stock | (9,135) |  |  | (8,315) |
Payment for employee taxes withheld from stock awards | (104) |  |  | (159) |
Net cash provided by (used in) financing activities | $ | (10,354) |  |  | $ | (9,322) |
Effect of foreign currency on cash | (35) |  |  | 268 |
Net change in cash and restricted cash | 12,256 |  |  | (12,430) |
Cash and restricted cash at beginning of period | 46,117 |  |  | 49,080 |
Cash and restricted cash at end of period | $ | 58,373 |  |  | $ | 36,650 |
Supplemental schedule of non-cash investing and financing activities: |  |  |
Shares issued for acquisitions (Note 12) | — |  |  | 527 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5

DXP ENTERPRISES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(in thousands) (unaudited)

| Series A preferred stock |  | Series B preferred stock |  | Common stock |  | Paid-in capital |  | Retained earnings |  | Treasury stock |  | Non controlling interest |  | Accum other comp loss |  | Total equity
Balance at December 31, 2021 | $ | 1 |  |  | $ | 15 |  |  | $ | 195 |  |  | $ | 206,772 |  |  | $ | 202,484 |  |  | $ | (33,511) |  |  | $ | 53 |  |  | $ | (29,282) |  |  | $ | 346,727 |
Preferred dividends paid | — |  |  | — |  |  | — |  |  | — |  |  | (23) |  |  | — |  |  | — |  |  | — |  |  | (23) |
Restricted stock compensation expense | — |  |  | — |  |  | — |  |  | 370 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 370 |
Tax related items for share based awards | — |  |  | — |  |  | — |  |  | (159) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (159) |
Issuance of shares of common stock | — |  |  | — |  |  | — |  |  | 527 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 527 |
Currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,669 |  |  | 1,669 |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,513) |  |  | — |  |  | — |  |  | (1,513) |
Net income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | 12,642 |  |  | — |  |  | (113) |  |  | — |  |  | 12,529 |
Balance at March 31, 2022 | $ | 1 |  |  | $ | 15 |  |  | $ | 195 |  |  | $ | 207,510 |  |  | $ | 215,103 |  |  | $ | (35,024) |  |  | $ | (60) |  |  | $ | (27,613) |  |  | $ | 360,127 |

| Series A preferred stock |  | Series B preferred stock |  | Common stock |  | Paid-in capital |  | Retained earnings |  | Treasury stock |  | Non controlling interest |  | Accum other comp loss |  | Total equity
Balance at December 31, 2022 | $ | 1 |  |  | $ | 15 |  |  | $ | 345 |  |  | $ | 213,937 |  |  | $ | 250,549 |  |  | $ | (67,780) |  |  | $ | — |  |  | $ | (31,675) |  |  | $ | 365,392 |
Preferred dividends paid | — |  |  | — |  |  | — |  |  | — |  |  | (23) |  |  | — |  |  | — |  |  | — |  |  | (23) |
Restricted stock compensation expense | — |  |  | — |  |  | — |  |  | 476 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 476 |
Tax related items for share based awards | — |  |  | — |  |  | — |  |  | (104) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (104) |
Currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 98 |  |  | 98 |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (9,135) |  |  | — |  |  | — |  |  | (9,135) |
Net income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | 17,580 |  |  | — |  |  | — |  |  | — |  |  | 17,580 |
Balance at March 31, 2023 | $ | 1 |  |  | $ | 15 |  |  | $ | 345 |  |  | $ | 214,309 |  |  | $ | 268,106 |  |  | $ | (76,915) |  |  | $ | — |  |  | $ | (31,577) |  |  | $ | 374,284 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
6

DXP ENTERPRISES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 - THE COMPANY
DXP Enterprises, Inc. together with its subsidiaries (collectively "DXP," "Company," "us," "we," or "our") was incorporated in Texas on July 26, 1996. DXP Enterprises, Inc. and its subsidiaries are engaged in the business of distributing maintenance, repair and operating ("MRO") products and services to a variety of end markets and industrial customers. Additionally, DXP provides integrated, custom pump skid packages, pump remanufacturing and manufactures branded private label pumps to energy and industrial customers. The Company is organized into three business segments: Service Centers ("SC"), Supply Chain Services ("SCS") and Innovative Pumping Solutions ("IPS"). See Note 11 - Segment Reporting for discussion of the business segments.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING AND BUSINESS POLICIES
Basis of Presentation
The Company's financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The accompanying unaudited condensed consolidated financial statements have been prepared on substantially the same basis as our annual consolidated financial statements and should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022. For a more complete discussion of our significant accounting policies and business practices, refer to the consolidated Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 17, 2023. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results expected for the full fiscal year. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for the fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented.
All inter-company accounts and transactions have been eliminated in consolidation.
NOTE 3 - RECENT ISSUED ACCOUNTING PRONOUNCEMENTS
The Company has implemented all new accounting pronouncements that are in effect and is evaluating any that may impact its financial statements, including the new Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers standard. The Company does not have any acquisitions during the current period and does not believe the new accounting pronouncement to have a material impact on its financial position or results of operations for recent acquisitions..
Accounting Pronouncements Not Yet Adopted
All other new accounting pronouncements that have been issued, but not yet effective, are currently being evaluated and at this time are not expected to have a material impact on our financial position or results of operations.
NOTE 4 - FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES
Authoritative guidance for financial assets and liabilities measured on a recurring basis applies to all financial assets and financial liabilities that are being measured and reported on a fair value basis. Fair value, as defined in the authoritative guidance, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative guidance affects the fair value measurement of an investment with quoted market prices in an active market for identical instruments, which must be classified in one of the following categories:
Level 1 inputs come from quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 inputs are other than quoted prices that are observable for an asset or liability. These inputs include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.
7

Level 3 inputs are unobservable inputs for an asset or liability which require the Company's own assumptions. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.
Our acquisitions may include contingent consideration as part of the purchase price. The fair value of the contingent consideration is estimated as of the acquisition date based on the present value of the contingent payments to be made using a weighted probability of possible payments. The unobservable inputs used in the determination of the fair value of the contingent consideration include management's assumptions about the likelihood of payment based on the established benchmarks, discount rates, and an internal rate of return analysis. The fair value measurement includes inputs that are Level 3 inputs as discussed above, as they are not observable in the market. Should actual results increase or decrease as compared to the assumptions used in our analysis, the fair value of the contingent consideration obligations will increase or decrease, up to the contracted limit, as applicable. Changes in the fair value of the contingent earn-out consideration are measured each reporting period and reflected in our results of operations.
As of March 31, 2023, we recorded liabilities in other current and long-term liabilities for contingent consideration associated with the acquisitions of Process Machinery, Inc. ("PMI"), Burlingame Engineers, Inc. ("Burlingame"), Drydon Equipment, Inc. ("Drydon"), Cisco Air Systems, Inc. ("Cisco") and Sullivan Environmental Technologies, Inc. ("Sullivan") of $1.2 million, $0.5 million, $2.8 million, $4.8 million, and $1.2 million, respectively. For the Company's assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the following table provides a reconciliation of the beginning and ending balances for each category therein, and gains or losses recognized during the three months ended March 31, 2023:

Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
| Contingent Liability for Accrued Consideration
| (in thousands)
*Beginning balance at December 31, 2022 | $ | 10,166 |
Changes in fair value recorded in other (income) expense, net | 342 |
*Ending Balance at March 31, 2023 | $ | 10,508 |
Total losses included in earnings or changes to net assets, attributable to changes in unrealized losses relating to liabilities still held at March 31, 2023. | $ | 342 |
*Amounts included in other current liabilities were $5.7 million and $5.5 million for the periods ending March 31, 2023 and December 31, 2022, respectively. Amounts included in long-term liabilities were $4.8 million and $4.7 million for the periods ending March 31, 2023 and December 31, 2022, respectively. |

Quantitative Information about Level 3 Fair Value Measurements
The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:

(in thousands, unaudited) | Fair value at March 31, 2023 | Valuation Technique | Significant Unobservable Inputs
Contingent consideration: (PMI, Burlingame, Drydon, Cisco and Sullivan acquisitions) | $ | 10,508 |  | Discounted cash flow and weighted probability of possible payments | Annualized EBITDA and probability of achievement

8

Sensitivity to Changes in Significant Unobservable Inputs
As presented in the table above, the significant unobservable inputs used in the fair value measurement of contingent consideration related to the acquisitions of PMI, Burlingame, Drydon, Cisco and Sullivan are annualized EBITDA forecasts developed by the Company's management and the probability of achievement of those EBITDA results. The discount rate used in the calculation was 8.1 percent. Changes in our unobservable inputs in isolation would result in a change to our fair value measurement.
Other financial instruments not measured at fair value on the Company's unaudited condensed consolidated balance sheets at March 31, 2023 and December 31, 2022, but which require disclosure of their fair values include: cash, trade accounts receivable, trade accounts payable and accrued expenses, accrued payroll and related benefits, and the revolving line of credit and term loan debt under our syndicated credit agreement facility (Note 8). The Company believes that the estimated fair value of such instruments at March 31, 2023 and December 31, 2022 approximates their carrying value as reported on the unaudited condensed consolidated balance sheets.
NOTE 5 – INVENTORIES
The carrying values of inventories are as follows (in thousands):

| March 31, 2023 |  | December 31, 2022
Finished goods | $ | 106,039 |  |  | $ | 82,906 |
Work in process | 3,364 |  |  | 18,486 |
Inventories | $ | 109,403 |  |  | $ | 101,392 |

NOTE 6 – CONTRACT ASSETS AND LIABILITIES
Under our customized pump production and long-term water and wastewater project contracts in our IPS segment, amounts are billed as work progresses in accordance with agreed-upon contractual terms, upon various measures of performance, including achievement of certain milestones, completion of specified units, or completion of a contract. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. Our contract assets are presented as “Cost and estimated profits in excess of billings” on our unaudited condensed consolidated balance sheets. However, we sometimes receive advances or deposits from our customers before revenue is recognized, resulting in contract liabilities that are presented as “Billings in excess of costs and estimated profits” on our unaudited condensed consolidated balance sheets.
Costs and estimated profits on uncompleted contracts and related amounts billed were as follows (in thousands):

| March 31, 2023 |  | December 31, 2022
Costs incurred on uncompleted contracts | $ | 94,100 |  |  | $ | 70,329 |
Estimated profits, thereon | 28,096 |  |  | 23,274 |
Total costs and estimated profits on uncompleted contracts | 122,196 |  |  | 93,603 |
Less: billings to date | 90,412 |  |  | 80,421 |
Net | $ | 31,784 |  |  | $ | 13,182 |

Such amounts were included in the accompanying unaudited condensed consolidated balance sheets for March 31, 2023 and December 31, 2022 under the following captions (in thousands):

| March 31, 2023 |  | December 31, 2022
Costs and estimated profits in excess of billings | $ | 41,967 |  |  | $ | 23,588 |
Billings in excess of costs and estimated profits | (10,183) |  |  | (10,411) |
Translation adjustment | — |  |  | 5 |
Net | $ | 31,784 |  |  | $ | 13,182 |

During the three months ended March 31, 2023, $9.7 million of the balances that were previously classified as contract liabilities at the beginning of the period were recognized in revenues. Contract asset and liability changes were primarily due to normal activity and timing differences between our performance and customer payments.
9

NOTE 7 – INCOME TAXES
Income tax expense during interim periods is based on our estimated annual effective income tax rate plus any discrete items, which are recorded in the period in which they occur. Our effective tax rate from continuing operations was a tax expense of 27.9 percent for the three months ended March 31, 2023 compared to a tax expense of 21.0 percent for the three months ended March 31, 2022. Compared to the U.S. statutory rate for the three months ended March 31, 2023, the effective tax rate was increased by state taxes, foreign taxes, nondeductible expenses, and uncertain tax positions recorded for research and development tax credits and was partially offset by research and development tax credits and other tax credits.
To the extent penalties and interest would be assessed on any underpayment of income tax, such accrued amounts would be classified as a component of income tax provision (benefit) in the financial statements consistent with the Company’s policy.
NOTE 8 – LONG-TERM DEBT
The components of the Company's long-term debt consisted of the following (in thousands):

| March 31, 2023 |  | December 31, 2022
| Carrying Value (1) |  | Fair Value |  | Carrying Value (1) |  | Fair Value
ABL Revolver | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Term Loan B | 427,041 |  |  | 407,824 |  |  | 428,133 |  |  | 411,008 |
Total long-term debt | 427,041 |  |  | 407,824 |  |  | 428,133 |  |  | 411,008 |
Less: current portion | (4,369) |  |  | (4,172) |  |  | (4,369) |  |  | (4,194) |
Long-term debt less current maturities | $ | 422,672 |  |  | $ | 403,652 |  |  | $ | 423,764 |  |  | $ | 406,814 |

(1) Carrying value amounts do not include unamortized debt issuance costs of $13.9 million and $14.6 million for March 31, 2023 and December 31, 2022, respectively.
Credit Agreements
On July 19, 2022, the Company entered into an Amended and Restated Loan and Security Agreement (the “ABL Credit Agreement”) that provided for a $135.0 million asset-backed revolving line of credit (the "ABL Revolver"). The ABL Credit Agreement amends and restates the Loan and Security Agreement dated as of August 29, 2017. Subject to the conditions set forth in the ABL Credit Agreement, the ABL Revolver may be increased by up to an aggregate of $50.0 million, in minimum increments of $10.0 million. The ABL Revolver matures on July 19, 2027. As of March 31, 2023, the Company had no borrowings outstanding under the ABL Revolver. Total borrowing capacity under the ABL Revolver was $132.4 million, net of the letters of credit outstanding.
On November 22, 2022, the Company entered into an amendment to its existing $330 million Senior Secured Term Loan (the "Term Loan Amendment"), borrowing an additional $105 million that was added to the existing $330 million Senior Secured Term Loan (the “Term Loan Agreement”). As of March 31, 2023 there was $427.0 million outstanding under the Term Loan Agreement.
The Company was in compliance with all financial covenants under the ABL Revolver and Term Loan B Agreements as of March 31, 2023.
10

NOTE 9 - EARNINGS PER SHARE DATA
Basic earnings per share is computed based on weighted average shares outstanding and excludes dilutive securities. Diluted earnings per share is computed including the impacts of all potentially dilutive securities.
The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):

| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Basic: |  |  |  |  |  |  |
Weighted average shares outstanding | 17,596 |  |  | 18,534 |  |  |  |  |
Net income attributable to DXP Enterprises, Inc. | $ | 17,580 |  |  | $ | 12,642 |  |  |  |  |
Convertible preferred stock dividend | 23 |  |  | 23 |  |  |  |  |
Net income attributable to common shareholders | $ | 17,557 |  |  | $ | 12,619 |  |  |  |  |
Per share amount | $ | 1.00 |  |  | $ | 0.68 |  |  |  |  |
Diluted: |  |  |  |  |  |  |
Weighted average shares outstanding | 17,596 |  |  | 18,534 |  |  |  |  |
Assumed conversion of convertible preferred stock | 840 |  |  | 840 |  |  |  |  |
Total dilutive shares | 18,436 |  |  | 19,374 |  |  |  |  |
Net income attributable to common shareholders | $ | 17,557 |  |  | $ | 12,619 |  |  |  |  |
Convertible preferred stock dividend | 23 |  |  | 23 |  |  |  |  |
Net income attributable to DXP Enterprises, Inc. | $ | 17,580 |  |  | $ | 12,642 |  |  |  |  |
Per share amount | $ | 0.95 |  |  | $ | 0.65 |  |  |  |  |

NOTE 10 - COMMITMENTS AND CONTINGENCIES
From time to time, the Company is a party to various legal proceedings arising in the ordinary course of business. While DXP is unable to predict the outcome or estimate the financial impact of these disputes, it believes that the ultimate resolution will not have, either individually or in the aggregate, a material adverse effect on DXP's consolidated financial position, cash flows, or results of operations.
NOTE 11 - SEGMENT REPORTING
The Company's reportable business segments are: Service Centers, Innovative Pumping Solutions and Supply Chain Services. The Service Centers segment is engaged in providing MRO products, equipment and integrated services, including logistics capabilities, to industrial customers. The Service Centers segment provides a wide range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, industrial supply, safety products and safety services categories. The Innovative Pumping Solutions segment fabricates and assembles custom-made pump packages, re-manufactures pumps, manufactures branded private label pumps and provides products and process lines for the water and wastewater treatment industries. The Supply Chain Services segment provides a wide range of MRO products and manages all or part of a customer's supply chain, including warehouse and inventory management.
Sales are shown net of inter-segment eliminations.
The following table sets out financial information related to the Company's segments excluding amortization (in thousands):
11

| Three Months Ended March 31,
| 2023 |  | 2022
| SC |  | IPS |  | SCS |  | Total |  | SC |  | IPS |  | SCS |  | Total
Total Revenue | $ | 295,226 |  |  | $ | 61,998 |  |  | $ | 67,043 |  |  | $ | 424,267 |  |  | 218,797 |  |  | 53,058 |  |  | 47,556 |  |  | $ | 319,411 |
Income from operations | $ | 44,705 |  |  | $ | 10,305 |  |  | $ | 5,514 |  |  | $ | 60,524 |  |  | $ | 27,351 |  |  | $ | 7,069 |  |  | $ | 4,020 |  |  | $ | 38,440 |

The following table presents reconciliations of operating income for reportable segments to the consolidated income before taxes (in thousands):

| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
Income from operations for reportable segments | $ | 60,524 |  |  | $ | 38,440 |  |  |  |  |
Adjustment for: |  |  |  |  |  |  |
Amortization of intangible assets | 4,758 |  |  | 4,235 |  |  |  |  |
Corporate expenses | 20,367 |  |  | 12,646 |  |  |  |  |
Income from operations | $ | 35,399 |  |  | $ | 21,559 |  |  |  |  |
Interest expense | 11,521 |  |  | 5,162 |  |  |  |  |
Other expense (income), net | (469) |  |  | 536 |  |  |  |  |
Income before income taxes | $ | 24,347 |  |  | $ | 15,861 |  |  |  |  |

NOTE 12 - SHARE REPURCHASE
On December 15, 2022, the Company announced a new Share Repurchase Program pursuant to which it may repurchase up to $85.0 million worth, or 2.8 million shares of the Company's outstanding common stock over the next 24 months.
During the three months ended March 31, 2023, the Company repurchased 339,535 shares of its common stock for approximately $9.1 million compared to 58,887 shares of its common stock for approximately $1.5 million for the three months ended March 31, 2022.
Total consideration paid to repurchase the shares was recorded in shareholders’ equity as treasury shares.

| Three Months Ended March 31, |  | Three Months Ended March 31,
(in thousands, except per share data) | 2023 |  | 2022
Total number of shares purchased | 339.5 |  |  | 58.9 |
Amount paid | $ | 9,135 |  |  | $ | 1,511 |
Average price paid per share | $ | 27.26 |  |  | $ | 25.66 |

12

NOTE 13 - SUBSEQUENT EVENT
On May 1, 2023, the Company completed the acquisition of Florida Valve & Equipment, LLC and Environmental MD, Inc., (collectively, “Florida Valve EMD”). Florida Valve EMD is a leading provider of valve and related products and services for the municipal water markets in the State of Florida. Total consideration for the transaction was approximately $3.0 million, funded with cash on hand. The preliminary purchase price allocation is not complete as of the date of this quarterly financial issuance and will be an ongoing process for up to one year subsequent to the closing date of the transaction.
On May 1, 2023, the Company completed the acquisition of Riordan Materials Corporation (“Riordan”). Riordan is a leading provider of products for water treatment, wastewater treatment, odor control, solids handling, pumping and bio solid processes in the States of Maryland, New Jersey, Pennsylvania, Delaware and Virginia. Total consideration for the transaction was approximately $6.2 million, funded with cash on hand. The preliminary purchase price allocation is not complete as of the date of this quarterly financial issuance and will be an ongoing process for up to one year subsequent to the closing date of the transaction.
13

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following management discussion and analysis ("MD&A") of the financial condition and results of operations of DXP Enterprises, Inc. together with its subsidiaries (collectively "DXP," "Company," "us," "we," or "our") for the three months ended March 31, 2023 should be read in conjunction with our previous Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, and the consolidated financial statements and notes thereto included in such reports. The Company's consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP").
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (this "Report") contains statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include without limitation those about the Company’s expectations regarding the long-term impacts of the COVID-19 pandemic, the prolonged Ukrainian/Russia conflict and its impact on commodity prices; particularly oil and gas; the Company’s business, the Company’s future profitability, cash flow, liquidity, and growth. Such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "might", "estimates", "will", "should", "could", "would", "suspect", "potential", "current", "achieve", "plans" or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy. Any such forward-looking statements are not guarantees of future performance and may involve significant risks and uncertainties, and actual results may vary materially from those discussed in the forward-looking statements or historical performance as a result of various factors. These factors include, but are not limited to, the effectiveness of management's strategies and decisions; our ability to implement our internal growth and acquisition growth strategies; general economic and business conditions specific to our primary customers; changes in government regulations; our ability to effectively integrate businesses we may acquire; new or modified statutory or regulatory requirements; availability of materials and labor; inability to obtain or delay in obtaining government or third-party approvals and permits; non-performance by third parties of their contractual obligations; unforeseen hazards such as weather conditions, acts of war or terrorist acts and the governmental or military response thereto; cyber-attacks adversely affecting our operations; other geological, operating and economic considerations and declining prices and market conditions, including reduced oil and gas prices and supply or demand for maintenance, repair and operating products, equipment and service; decreases in oil and natural gas industry capital expenditure levels, which may result from decreased oil and natural gas prices or other factors; economic risks related to the long-term impact of COVID-19; our ability to manage changes and the continued health or availability of management personnel; and our ability to obtain financing on favorable terms or amend our credit facilities, as needed. This Report identifies other factors that could cause such differences. We cannot assure that these are all of the factors that could cause actual results to vary materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in "Risk Factors", in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 17, 2023. We assume no obligation and do not intend to update these forward-looking statements. Unless the context otherwise requires, references in this Report to the "Company", "DXP", "we" or "our" shall mean DXP Enterprises, Inc., a Texas corporation, together with its subsidiaries.
CURRENT MARKET CONDITIONS AND OUTLOOK
General
DXP Enterprises, Inc. is a business-to-business distributor of MRO products and services to a variety of customers in different end markets primarily across North America. Additionally, we fabricate, remanufacture and assemble custom pump packages along with manufacturing branded private label pumps.
Inflation Reduction Act
In August 2022, the Inflation Reduction Act of 2022 (IRA) was signed into United States (U.S.) law. The IRA establishes a new 15% corporate minimum tax and a new 1% excise tax on stock repurchases, effective after December 31, 2022. In addition, the IRA contains provisions relating to climate change, energy and health care. Based on the Company's current analysis of the provisions, the Company does not anticipate a material impact to the consolidated financial statements as a result of the IRA.
14

Inflation
The global commodity and labor markets experienced significant inflationary pressures attributable to economic recovery and supply chain issues tightening caused by the COVID-19 pandemic and the Ukrainian-Russia conflict, among other factors. These inflationary trends increased the cost of many of the products we buy. As a distributor, we often remain neutral to inflation as those costs are generally passed on to customers. The Company was able to pass price increases on to customers and implement other strategies designed to mitigate some of the adverse effects of higher costs during the three months ended March 31, 2023.
Outlook
Service Centers and Supply Chain Services Segments
The replacement and mission-critical nature of our products and services within the Company's Service Centers and Supply Chain Services business segments and industrial and manufacturing environments and processes drives a demand and outlook that are correlated with global, national and regional industrial production, capacity utilization and long-term GDP growth. The Company's recent order activity improved as markets strengthened. For the three months ended March 31, 2023, we had approximately $362.3 million in sales in our Service Centers and Supply Chain Services segments, an increase of approximately 36.0 percent compared to the three months ended March 31, 2022. Our performance has been strengthened by price increases from our vendors and suppliers that we typically pass through to our customers. During 2022 and into the first quarter of 2023 we have benefited from these price increases. As we move into the second quarter and second half of 2023, we expect the impact of these price increases to moderate.
Innovative Pumping Solutions Segment
For the three months ended March 31, 2023, we had approximately $62.0 million in sales in our Innovative Pumping Solutions segment, an increase of approximately $8.9 million compared to the three months ended March 31, 2022, of which $3.3 million was associated with recent acquisitions in the water and wastewater markets. Beginning in the second half of 2021, we began to see an improvement in the demand for oil and natural gas as the roll out of the COVID-19 vaccinations gradually improved around the globe and pandemic restrictions eased. The increasing optimism related to oil and gas demand recovery led to higher commodity prices. Although demand levels remained below pre-pandemic levels, there is growing confidence of returning to 2019 levels in the coming years. In the first quarter of 2022, the Ukrainian-Russia conflict caused further disruption in the global oil and gas supply and spurred price increases around the world. These forces contributed to higher spending by oil and gas producers, and thus, an increase in oil and gas projects within our Innovative Pumping Solutions segment. We expect to benefit from the increased oil and gas activity throughout 2023. Additionally, we expect to benefit from the recent water and wastewater acquisitions as we continue to scale this platform both organically and by positioning DXP Water to bid on projects that historically may have not been available to the separate acquisitions on a standalone basis.
15

RESULTS OF OPERATIONS
(in thousands, except percentages and per share data)
DXP is organized into three business segments: Service Centers ("SC"), Supply Chain Services ("SCS") and Innovative Pumping Solutions ("IPS"). The Service Centers are engaged in providing MRO products, equipment and integrated services, including technical expertise and logistics capabilities, to industrial customers with the ability to provide same day delivery. The Service Centers provide a wide range of MRO products and services in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, industrial supply and safety product and service categories. The SCS segment provides a wide range of MRO products and manages all or part of our customer's supply chain function, and inventory management. The IPS segment provides products and services to the water and wastewater market and fabricates and assembles integrated pump system packages custom made to customer specifications, remanufactures pumps, and manufactures branded private label pumps.

| Three Months Ended March 31,
| 2023 |  | % |  | 2022 |  | %
Sales | $ | 424,267 |  |  | 100.0 | % |  | $ | 319,411 |  |  | 100.0 | %
Cost of sales | 299,226 |  |  | 70.5 | % |  | 224,527 |  |  | 70.3 | %
Gross profit | $ | 125,041 |  |  | 29.5 | % |  | $ | 94,884 |  |  | 29.7 | %
Selling, general and administrative expenses | 89,642 |  |  | 21.1 | % |  | 73,325 |  |  | 23.0 | %
Income from operations | $ | 35,399 |  |  | 8.3 | % |  | $ | 21,559 |  |  | 6.7 | %
Other expense (income), net | (469) |  |  | (0.1) | % |  | 536 |  |  | 0.2 | %
Interest expense | 11,521 |  |  | 2.7 | % |  | 5,162 |  |  | 1.6 | %
Income before income taxes | $ | 24,347 |  |  | 5.7 | % |  | $ | 15,861 |  |  | 5.0 | %
Provision for income tax expense (benefit) | 6,767 |  |  | 1.6 | % |  | 3,332 |  |  | 1.0 | %
Net income | $ | 17,580 |  |  | 4.1 | % |  | $ | 12,529 |  |  | 3.9 | %
Net loss attributable to noncontrolling interest | — |  |  | — |  |  | (113) |  |  | — |
Net income attributable to DXP Enterprises, Inc. | $ | 17,580 |  |  | 4.1 | % |  | $ | 12,642 |  |  | 4.0 | %
Per share amounts attributable to DXP Enterprises, Inc. |  |  |  |  |  |  |
Basic earnings per share | 1.00 |  |  |  |  | $ | 0.68 |  |  |
Diluted earnings per share | 0.95 |  |  |  |  | $ | 0.65 |  |  |

Three Months Ended March 31, 2023 compared to Three Months Ended March 31, 2022
SALES. Sales for the three months ended March 31, 2023 increased $104.9 million, or 32.8 percent, to approximately $424.3 million from $319.4 million for the prior year's corresponding period. Sales from businesses acquired in 2022 for three months ended March 31, 2023, accounted for $9.3 million of the sales. This overall sales increase is the result of an increase in sales in our SC, IPS and SCS segments of $76.4 million, $8.9 million, and $19.5 million, respectively. The fluctuations in sales are further explained in our business segment discussions below.

| Three Months Ended March 31,
| 2023 |  | 2022 |  | Change |  | Change%
Sales by Business Segment | (in thousands, except change %)
Service Centers | $ | 295,226 |  |  | $ | 218,797 |  |  | $ | 76,429 |  |  | 34.9 | %
Innovative Pumping Solutions | 61,998 |  |  | 53,058 |  |  | 8,940 |  |  | 16.8 | %
Supply Chain Services | 67,043 |  |  | 47,556 |  |  | 19,487 |  |  | 41.0 | %
Total DXP Sales | $ | 424,267 |  |  | $ | 319,411 |  |  | $ | 104,856 |  |  | 32.8 | %

16

Service Centers segment. Sales for the SC segment increased by approximately $76.4 million, or 34.9 percent, for the three months ended March 31, 2023, compared to the prior year's corresponding period. Excluding $6.0 million of SC segment sales associated with acquisitions in the prior period, sales increased $70.4 million from the prior year's corresponding period. This sales increase is primarily the result of increased sales of rotating equipment and bearings and power transmission products to customers engaged in variety of markets.
Innovative Pumping Solutions segment. Sales for the IPS segment increased by $8.9 million, or 16.9 percent, for the three months ended March 31, 2023, compared to the prior year's corresponding period. Excluding $3.3 million of IPS segment sales from acquisitions in the prior period, IPS segment sales increased $5.6 million from the prior year's corresponding period. This increase was primarily the result of an increase in the capital spending by oil and gas producers and related businesses.
Supply Chain Services segment. Sales for the SCS segment increased by $19.5 million, or 41.0 percent, for the three months ended March 31, 2023, compared to the prior year's corresponding period. The improved sales are primarily related to the addition of a new customer in the diversified chemicals market, as well as sales increases in the medical technology, food and beverage and oil and gas markets.
GROSS PROFIT. Gross profit as a percentage of sales for the three months ended March 31, 2023 was 29.5 percent versus 29.7 percent in the prior year's corresponding period. Excluding the impact of the businesses acquired in the prior period, gross profit as a percentage of sales was 29.2 percent. The decrease in the gross profit percentage excluding the businesses acquired is primarily the result of a decrease in gross profit within our SCS segment.
Service Centers segment. As a percentage of sales, for the three months ended March 31, 2023 gross profit percentage for the SC segment increased approximately 20 basis points. Excluding for the businesses acquired in the prior period, gross profit as a percentage of sales decreased approximately 30 basis points from the prior year's corresponding period. This was primarily the result of product mix. Gross profit for the SC segment, excluding businesses acquired in the prior period, increased $20.9 million, or 30.9 percent, during the three months ended March 31, 2023 compared to the prior year’s corresponding period.
Innovative Pumping Solutions segment. As a percentage of sales, for the three months ended March 31, 2023 gross profit percentage for the IPS segment increased approximately 185 basis points. Excluding for the businesses acquired, gross profit as a percentage of sales increased approximately 235 basis points from the prior year's corresponding period. The aforementioned increase in gross profit percentage as a percentage of sales is primarily due to the addition of higher water and wastewater projects versus lower margin oil and gas work and gross margin improvements within oil and gas. Gross profit increased $3.1 million compared to the prior year corresponding period, excluding business acquired, primarily as a result of an increase in project work caused by an increase in capital spending by our customers.
Supply Chain Services segment. As a percentage of sales, for the three months ended March 31, 2023 gross profit percentage for the SCS segment decreased approximately 375 basis points compared to the prior year's corresponding period. Gross profit for the first quarter of 2023 increased $2.1 million, or 18.8 percent, compared to the prior year's corresponding period primarily due to the addition of a new customer in the diversified chemicals market.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES ("SG&A"). SG&A for the three months ended March 31, 2023 increased by approximately $16.3 million, or 22.3 percent, to $89.6 million from $73.3 million for the prior year's corresponding period. SG&A from businesses acquired accounted for $2.0 million. Excluding expenses from businesses acquired, SG&A for the quarter increased by $14.3 million, or 19.5 percent, compared to the prior year's corresponding period. The increase in SG&A excluding businesses acquired is primarily the result of increased payroll, incentive compensation and related taxes and 401(k) expenses as a result of increased business activity.
OPERATING INCOME. Operating income for the first quarter of 2023 increased by $13.8 million to $35.4 million, from $21.6 million in the prior year's corresponding period. This increase in operating income is related to the aforementioned increase in business activity across all segments and reduction in SG&A as a percentage of sales in the current period versus the prior year's corresponding period.
INTEREST EXPENSE. Interest expense for the first quarter of 2023 increased $6.4 million compared to the prior year's corresponding period. This increase was primarily due to the Company borrowing an additional $105.0 million on its Term Loan B during the fourth quarter of 2022 and incurring higher than average interest rates on such debt due to changes in the macroeconomic environment and the associated increasing interest rate policy by the U.S. Federal Reserve Bank.
17

INCOME TAXES. Our effective tax rate from continuing operations was a tax expense of 27.9 percent for the three months ended March 31, 2023, compared to a tax expense of 21.0 percent for the three months ended March 31, 2022. Compared to the U.S. statutory rate for the three months ended March 31, 2023, the effective tax rate was increased by state taxes, foreign taxes, nondeductible expenses, and uncertain tax positions recorded for research and development tax credits and was partially offset by research and development tax credits and other tax credits.
LIQUIDITY AND CAPITAL RESOURCES
General Overview
As of March 31, 2023, we had cash and restricted cash of $58.4 million and credit facility availability of $132.4 million. We have a $135.0 million asset backed revolving line of credit (the "ABL Revolver"), partially offset by letters of credit of $2.6 million. We had no borrowings outstanding on our ABL Revolver as of March 31, 2023. We had $427.0 million in borrowings on our Term Loan B as of March 31, 2023. On July 19, 2022, the Company amended and extended the maturity date of the ABL Revolver to July 19, 2027.
Our primary source of capital is cash flow from operations, supplemented as necessary by bank borrowings or other sources of financing. As a distributor of MRO products and services and fabricator of custom pumps and packages, working capital can fluctuate as a result of changes in inventory levels, accounts receivable and costs in excess of billings for project work. Additional cash is required for capital items for information technology, warehouse equipment, leasehold improvements, pump manufacturing equipment and safety services equipment. We also require cash to pay our lease obligations and to service our debt.
The following table summarizes our net cash flows generated by operating activities, net cash used in investing activities and net cash used in financing activities for the periods presented (in thousands):

| Three Months Ended March 31,
| 2023 |  | 2022
Net Cash Provided by (Used in): |  |  |
Operating Activities | $ | 26,449 |  |  | $ | 2,680 |
Investing Activities | (3,804) |  |  | (6,056) |
Financing Activities | (10,354) |  |  | (9,322) |
Effect of Foreign Currency | (35) |  |  | 268 |
Net Change in Cash | $ | 12,256 |  |  | $ | (12,430) |

Operating Activities
The Company generated $26.4 million of cash from operating activities during the three months ended March 31, 2023 compared to $2.7 million of cash generated during the prior year's corresponding period. The $23.8 million increase in the amount of cash provided between the two periods was primarily due to increased business activity.
Investing Activities
For the three months ended March 31, 2023, net cash used in investing activities was $3.8 million compared to a $6.1 million use of cash during the prior year’s corresponding period. This $2.3 million decrease was primarily driven by a reduction in the total purchase price paid for acquisitions during the three months ended March 31, 2022 of $5.3 million without comparable activity during the three months ended March 31, 2023. The decrease was partially offset by purchases of property and equipment of $3.8 million for the three months ended March 31, 2023 compared to $740 thousand for the three months ended March 31, 2022.
Financing Activities
For the three months ended March 31, 2023, net cash used in financing activities was $10.4 million, compared to net cash used in financing activities of $9.3 million during the prior year’s corresponding period. The increase was primarily due to an increase of $0.8 million in share repurchases.
18

Funding Commitments
We intend to pursue additional acquisition targets, but the timing, size or success of any acquisition and the related potential capital commitments cannot be determined with certainty. We continue to expect to fund future acquisitions primarily with cash flows from operations and borrowings, including the undrawn portion of the credit facility or new debt issuances, but may also issue additional equity either directly or in connection with acquisitions. There can be no assurance that additional financing for acquisitions will be available at terms acceptable to the Company.
The Company believes it has adequate funding and liquidity to meet its normal working capital needs during the next twelve months. However, the Company may require additional debt outside of our credit facilities or equity financing to fund potential acquisitions. Such additional financings may include additional bank debt or the public or private sale of debt or equity securities. In connection with any such financing, the Company may issue securities that dilute the interests of our shareholders.
DISCUSSION OF SIGNIFICANT ACCOUNTING AND BUSINESS POLICIES
Critical accounting and business policies are those that are both most important to the portrayal of a company's financial position and results of operations, and require management's subjective or complex judgments. These policies have been discussed with the Audit Committee of the Board of Directors of DXP.
The Company's unaudited condensed financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The accompanying unaudited Condensed Consolidated Financial Statements have been prepared on substantially the same basis as our annual Consolidated Financial Statements and should be read in conjunction with our annual report on Form 10-K for the year ended December 31, 2022. For a more complete discussion of our significant accounting policies and business practices, refer to the consolidated annual report on Form 10-K filed with the Securities and Exchange Commission on April 17, 2023. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results expected for the full fiscal year.
RECENT ACCOUNTING PRONOUNCEMENTS
See Note 3 - Recent Accounting Pronouncements to the Condensed Consolidated Financial Statements for information regarding recent accounting pronouncements.
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
For quantitative and qualitative disclosures about market risk, see Item 7A, 'Quantitative and Qualitative Disclosures About Market Risk' of our Annual Report on Form 10-K for the year ended December 31, 2022. Our exposures to market risk have not changed materially since December 31, 2022.
19

ITEM 4: CONTROLS AND PROCEDURES.
With the participation of management, our principal executive officer and principal financial officer carried out an evaluation, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of March 31, 2023 because of the material weaknesses in internal control over financial reporting described below.
Notwithstanding these material weaknesses, our management, including our principal executive officer and principal financial officer, has concluded that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are fairly stated in all material respects in accordance with GAAP for each of the periods presented.
Material Weaknesses in Internal Control Over Financial Reporting
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. In connection with the preparation of our financial statements for 2020 and 2021, we identified certain control deficiencies in the design and operation of our internal control over financial reporting that constituted material weaknesses. The material weaknesses are:
Material weakness related to unvouchered purchase order receipts: We did not design and maintain effective controls over the timely clearing of discrepancies arising from our three-way-match process. Specifically, controls were not designed appropriately to ensure that aged items were properly cleared from the sub-ledger and ultimately accounts payable. This material weakness resulted in a restatement of previously reported results related to periods prior to December 31, 2020. Additionally, this material weakness could result in a misstatement of accounts and disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
Material weakness related to the application of percentage-of-completion (“POC”) accounting: We did not design and maintain effective controls over the completeness, occurrence, cut-off, accuracy and presentation and disclosure of revenue. Specifically, for revenue recognized under the percentage-of-completion input method, controls were not designed and maintained to ensure accuracy of the costs-to-date, estimates of the cost-to-complete and the determination of revenue recognized for certain project-based contracts. Additionally, within the Company's product sales and service revenue streams, controls were not designed and maintained to ensure the accuracy of the price and quantity, including the approval of credit memos, the existence of a customer contract, and appropriate cut-off during the revenue recognition process. This material weakness resulted in immaterial audit adjustments related to revenue and related contract assets and liabilities during the years ended December 31, 2021 and 2022, and out-of-period adjustments related to revenue during the year ended December 31, 2022. Additionally, this material weakness could result in a misstatement of accounts and disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
Material weakness related to the segregation of duties: We did not design and maintain effective controls over user roles and segregation of duties for functional access to transactions. As a result, there was a lack of segregation of duties within the Company's financial reporting function, specifically within the accounts payable, revenue, and journal entry processes. This material weakness did not result in adjustments to the consolidated financial statements. However, this material weakness could result in a material misstatement to the accounts and disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
Material weakness related to sufficient complement of resources: The Company lacked a sufficient complement of resources with (i) an appropriate level of accounting knowledge, experience and training to appropriately analyze, record and disclose accounting matters timely and accurately, and (ii) an appropriate level of knowledge and experience to establish effective processes and controls.
20

REMEDIATION PLAN FOR MATERIAL WEAKNESSES
To date we have implemented several process changes to limit the accumulation and aging of unmatched items. We continue to enhance policies and systems to timely clear discrepancies and prevent an accumulation of balances. Additionally, management is currently in the process of developing and implementing changes as a part of a comprehensive remediation plan to address the material weakness related to the application of POC accounting. We believe the remediation activities will extend through the remainder of fiscal year 2023.
Changes in Internal Control Over Financial Reporting
Except as described above, there were no changes in internal control over financial reporting identified in the evaluation for the quarter ended March 31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
21

PART II: OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
From time to time, the Company is a party to various legal proceedings arising in the ordinary course of business. While DXP is unable to predict the outcome of these lawsuits, it believes that the ultimate resolution will not have, either individually or in the aggregate, a material adverse effect on DXP's consolidated financial position, cash flows, or results of operations.
ITEM 1A. RISK FACTORS.
There have been no material changes to the risk factors as previously disclosed in “Part I. Item 1A. Risk Factors” in our annual report on Form 10-K for the year end December 31, 2022.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Recent Sales of Unregistered Securities
The Company did not sell any unregistered securities during the three months ended March 31, 2023.
Issuer Purchases of Equity Securities
A summary of our purchases of DXP Enterprises, Inc. common stock during the first quarter of fiscal year 2023 is as
follows:

|  | Total Number of Shares Purchased (1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2) |  | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) (2)
| Jan 1 -Jan 31 | 63,391 |  |  | $ | 27.97 |  |  | 63,391 |  |  | $ | 79,361 |
| Feb 1 - Feb 28 | 14,088 |  |  | 28.99 |  |  | 13,247 |  |  | 78,978 |
| Mar 1 -Mar 31 | 265,546 |  |  | 26.77 |  |  | 262,897 |  |  | 71,877 |
| Total | 343,025 |  |  | $ | 27.26 |  |  | 339,535 |  |  | $ | 71,877 |
(1) |  | There were 3,490 shares transferred from employees in satisfaction of minimum statutory tax withholding obligations upon the vesting of restricted stock during the three months ended March 31, 2023.
(2) |  | On December 15, 2022, the Company announced a new Share Repurchase Program pursuant to which it may repurchase up to $85.0 million worth, or 2.8 million shares, of the Company's outstanding common stock over the next 24 months. As of March 31, 2023, approximately $71.9 million worth of, or approximately 2.3 million, shares remained available under the $85.0 million Share Repurchase Program.

22

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
None.
ITEM 5. OTHER INFORMATION.
None.
23

ITEM 6. EXHIBITS.

3.1 | Restated Articles of Incorporation, as amended (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form on Form S-8, filed with the Commission on August 20, 1998. File No. :333-61953).

3.2 | Bylaws of DXP Enterprises, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q, filed with the SEC on May 10, 2018 (File No. 000-21513), as amended on July 27, 2011.

3.3 | Amendment to Section 3.4 of the Bylaws of DXP Enterprises, Inc., effective January 1, 2022. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 000-21513 : 21860170, filed with the Commission on April 27, 2021).
* 22.1 | Subsidiary Guarantors of Guaranteed Securities.
* 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended.

* 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended.

* 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*101 | The following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline eXtensible Business Reporting Language (iXBRL), (i) Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income, (ii) Unaudited Condensed Consolidated Balance Sheets, (iii) Unaudited Condensed Consolidated Statements of Cash Flows, (iv) Unaudited Condensed Consolidated Statements of Equity, and (v) Notes to Unaudited Condensed Consolidated Financial Statements.
*104 | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 formatted in XBRL.

Exhibits designated by the symbol * are filed or furnished with this Quarterly Report on Form 10-Q. All exhibits not so designated are incorporated by reference to a prior filing with the Commission as indicated.
24

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
DXP ENTERPRISES, INC.
(Registrant)
By: /s/ Kent Yee
Kent Yee
Senior Vice President and Chief Financial Officer
(Duly Authorized Signatory and Principal Financial Officer)
Dated: May 15, 2023
25